UĞUR TOPAL, AHMET ONUR DEMİREL, BURAK YAVUZ, İSHAK AYDIN, ORÇUN YALAV, İSMAİL CEM ERAY
Annals of Clinical and Analytical Medicine - 2024;15(11):748-752
Aim: Treating transverse colon cancer surgically can involve either extended colectomy or segmental resection, depending on tumor location and surgeon preference. This study explores our tertiary care center’s surgical approaches to transverse colon cancer. Material and methods: We analyzed patients with transverse colon adenocarcinoma who underwent curative transverse or segmental colectomy (2016-2021). Data included demographics, clinical presentation, surgical details, lymph node dissection, pathology, post-op outcomes, and survival. Results: This research included 15 patients (5 transverse colectomy, 10 extended hemicolectomy). Demographics were similar between groups. Minimally invasive surgery rates were 20% (transverse colectomy) and 40% (extended hemicolectomy). Operation time, anastomotic technique, and hospital stay didn’t significantly differ. Surgical site infection was the most common complication for both groups. Extended hemicolectomy yielded more dissected lymph nodes (p=0.028), but malignant lymph node count was similar. Pathology stages were not statistically different between groups, and average survival times were comparable. Discussion: Our study suggests similar postoperative outcomes for transverse colectomy and extended colectomy in transverse colon cancer. While extended colectomy yielded more lymph nodes, this didn’t significantly impact long-term survival. With careful patient selection, both techniques appear safe and feasible, despite the limited patient numbers in our study.
